The Chemours Company (CC) NYSE
21.55
+0.03(+0.14%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
21.55
+0.03(+0.14%)
Currency In USD
| Market Cap | 1.77B |
| Enterprise Value | 5.69B |
| P/E Ratio | -8.39 |
| PEG Ratio | 0.53 |
| Price/Sales Ratio | 0.56 |
| Price/Book Ratio | 12.96 |
| Enterprise/Revenue | 1.23 |
| Enterprise/EBITDA | 39.5 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.07 |
| Operating Margin | -0 |
| Return On Assets | -0.05 |
| Return On Equity | -1.13 |
| Revenue | 5.81B |
| Revenue/Share | 38.63 |
| Gross Profit | 902M |
| EBITDA | 332M |
| Net Income | -386M |
| Diluted EPS | -2.56 |
| Total Cash | 670M |
| Total Cash/Share | 4.46 |
| Total Debt | 4.59B |
| Total Debt/Equity | 18.34 |
| Current Ratio | 1.78 |
| Book Value Per Share | 1.67 |
| 52-Week Change | 88.7 |
| 52-Week High | 22.43 |
| 52-Week Low | 9.13 |
| Moving Average 50 Days | 18.37 |
| Moving Average 200 Days | 14.78 |
| Average Volume | 3.6M |
| Shares Outstanding | 150.09M |
| % Held by Institutions | 89.94 |
| Trailing Annual Dividend Rate | 0.35 |
| Trailing Annual Dividend Yield | 1.62 |
| Payout Ratio | -0.2 |
| Last Split Factor | N/A |
| Last Split Date | N/A |